Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Tinidazole for Recurrent Bacterial Vaginosis
NCT00324142Phase 2Withdrawn
- Sponsor
- Kaiser Permanente
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tinidazole in bacterial vaginosis (BV), sponsored by Kaiser Permanente. Status: withdrawn.
02
Drugs
tinidazole
03
Conditions
bacterial vaginosis (BV)
Beyond the preview
Go deeper on NCT00324142.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00324142.